The expression level of HER2 in the HBCx-51 tumor was taken as cut off for positivity, the patient's tumor of this PDX was classified as HER2 2+ in IHC based on international guidelines on HER2 scores (and without gene amplification) (Figure 2) [12]. The gene discussed is ERBB2; the disease is neoplasm.